MT Petrucci

Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells

Hironobu Hata, Hong Xiao, MT Petrucci et al. · Blood · 1993 · 136 citations · Full text

Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial

Meletios Α. Dimopoulos, Michel Delforge, Roman Hájek et al. · Haematologica · 2012 · 66 citations · Full text

Recombinant interferon alfa-2b (INTRON A) as post-induction therapy for responding multiple myeloma patients. M84 protocol

Franco Mandelli, M Tribalto, Giuseppe Avvisati et al. · Cancer Treatment Reviews · 1988 · 44 citations

Hematological Malignancy, Recombinant Interferon Alfa-2b, Oncology +6

Interleukin-9 stimulates the proliferation of human myeloid leukemic cells

Alessandra Fortuna, Agostino Tafuri, M Fogli et al. · Blood · 1996 · 34 citations · Full text

Incidence of second primary malignancy (SPM) in melphalan-prednisone-lenalidomide combination followed by lenalidomide maintenance (MPR-R) in newly diagnosed multiple myeloma patients (pts) age 65 or older.

Antonio Palumbo, M. Delforge, J. Catalano et al. · Journal of Clinical Oncology · 2011 · 26 citations

Mixed-phenotype Acute Leukemia, Pathology, Myeloid Neoplasia +17